These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 14508879
1. Vaccines for Moraxella catarrhalis and non-typeable Haemophilus influenzae. McMichael JC, Green BA. Curr Opin Investig Drugs; 2003 Aug; 4(8):953-8. PubMed ID: 14508879 [Abstract] [Full Text] [Related]
2. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Murphy TF. Expert Rev Vaccines; 2005 Dec; 4(6):843-53. PubMed ID: 16372880 [Abstract] [Full Text] [Related]
3. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Mason KW, Zhu D, Scheuer CA, McMichael JC, Zlotnick GW, Green BA. Vaccine; 2004 Sep 03; 22(25-26):3449-56. PubMed ID: 15308371 [Abstract] [Full Text] [Related]
5. Current progress with Moraxella catarrhalis antigens as vaccine candidates. Mawas F, Ho MM, Corbel MJ. Expert Rev Vaccines; 2009 Jan 03; 8(1):77-90. PubMed ID: 19093775 [Abstract] [Full Text] [Related]
6. Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development. Jalalvand F, Riesbeck K. Expert Rev Vaccines; 2018 Jun 03; 17(6):503-512. PubMed ID: 29863956 [Abstract] [Full Text] [Related]
8. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis. Tan TT, Riesbeck K. Expert Rev Vaccines; 2007 Dec 03; 6(6):949-56. PubMed ID: 18377357 [Abstract] [Full Text] [Related]
10. Serum antibodies specific to CD outer membrane protein of Moraxella catarrhalis, P6 outer membrane protein of non-typeable Haemophilus influenzae and capsular polysaccharides of Streptococcus pneumoniae in children with otitis media with effusion. Harabuchi Y, Murakata H, Goh M, Kodama H, Kataura A, Faden H, Murphy TF. Acta Otolaryngol; 1998 Nov 03; 118(6):826-32. PubMed ID: 9870628 [Abstract] [Full Text] [Related]
12. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R. J Antimicrob Chemother; 2009 Mar 03; 63(3):511-9. PubMed ID: 19174454 [Abstract] [Full Text] [Related]
14. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. Bertot GM, Becker PD, Guzmán CA, Grinstein S. J Infect Dis; 2004 Apr 01; 189(7):1304-12. PubMed ID: 15031801 [Abstract] [Full Text] [Related]
15. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx. Abe N, Kodama S, Hirano T, Eto M, Suzuki M. Laryngoscope; 2006 Mar 01; 116(3):407-12. PubMed ID: 16540899 [Abstract] [Full Text] [Related]
17. Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates. Hu WG, Berry J, Chen J, Gu XX. FEMS Immunol Med Microbiol; 2004 Jun 01; 41(2):109-15. PubMed ID: 15145454 [Abstract] [Full Text] [Related]
18. Recent advances in otitis media. 6. Vaccine. Giebink GS, Kurono Y, Bakaletz LO, Kyd JM, Barenkamp SJ, Murphy TF, Green B, Ogra PL, Gu XX, Patel JA, Heikkinen T, Pelton SI, Hotomi M, Karma P. Ann Otol Rhinol Laryngol Suppl; 2005 Jan 01; 194():86-103. PubMed ID: 15700938 [No Abstract] [Full Text] [Related]